DJIA 17,191.37 -195.84 -1.13%
NASDAQ 4,637.99 -43.50 -0.93%
S&P 500 2,002.16 -27.39 -1.35%
market minute promo

Geron Corp (NASDAQ: GERN)

3.28 -0.09 (-2.67%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GERN $3.28 -2.67%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.40
Previous Close $3.37
Daily Range $3.26 - $3.44
52-Week Range $1.39 - $5.54
Market Cap $515.7M
P/E Ratio -13.48
Dividend (Yield) $0.00 (0.0%)
Volume 1,934,895
Average Daily Volume 3,097,138
Current FY EPS $0.00





Geron Corp (GERN) Description

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS. Website:

News & Commentary Rss Feed

The Small-Cap Stock I'm Watching in 2015

Three Motley Fools tell investors which small-cap stocks they'll be watching in 2015.

30 Reasons I Like Geron

Has Geron Undersold Itself To Janssen?

Trade-Ideas: Geron (GERN) Is Today's Strong On High Relative Volume Stock

It's Time To Invest In Geron: Johnson & Johnson Thinks So

3 Biotech Stocks That Could Double in 2015

Three Motley Fool contributors tell us which biotech stocks they think could make a big move next year.

Geron Enters 2015 On A More Assured Note

Market Has Not Yet Noticed Potential in Geron (GERN); Have You? - Tale of the Tape

4 Top Ranked Biotech Stocks that Beat the Market in 2014 - Analyst Blog

Today's Dead Cat Bounce Stock: Geron (GERN)

See More GERN News...

GERN's Top Competitors

GERN $3.28 (-2.67%)
Current stock: GERN
AMGN $154.64 (-2.67%)
Current stock: AMGN
GILD $102.45 (-2.46%)
Current stock: GILD
BIIB $351.18 (-1.87%)
Current stock: BIIB